AVIENT CORPORATION
In the published model solve dated 2026-Q2, anchored at $43.40, AVIENT CORPORATION (AVNT) is priced for +14.5% growth. boothcheck publishes no house fair value, target price, or buy/sell rating; individual model outputs and user-controlled scenarios are analytical inputs, not Boothcheck targets. The narrative was composed July 25, 2026 from SEC EDGAR filings.
• Avient does not make plastic, it formulates it: colorants, additives and engineered compounds built to a customer's specification, including what the 10-K calls ⟦a full range of thermoset and thermoplastic composites, reinforced with glass, carbon, aramid, and ultrahigh molecular weight polyethylene fibers⟧. • The business is geographically spread rather than concentrated, with roughly 40% of sales in the United States and Canada, 36% in EMEA and 18% in Asia, which diversifies the demand cycle
Is AVNT overvalued? See what's priced in →
331 institutional managers reported holding AVNT in 13F filings for the quarter ended 2026-03-31. 49 opened new positions that quarter. Held by BlackRock, Vanguard Group, Dimensional Fund Advisors, among others. On the short side, 2.8M shares were sold short as of the 2026-06-15 count, about 3% of shares outstanding (3.4 days of typical volume to cover).
Quarterly 13F filings arrive up to 45 days after quarter end, so the picture is never current (filed through 2026-05-29). Nothing here is investment advice.
AVNT's share count is about flat over the past five years ($36.40M of repurchases, offset by issuance). It pays a dividend, and has for 12 years running, raised 11 years straight; the current rate is $1.08 a share annually. Cash returned over the past three years: $263.20M in dividends.
Share counts are split-adjusted; repurchase totals are gross of share issuance. Nothing here is investment advice.
Open-market insider buys at AVNT over the trailing three years: 2023: 1 buy totaling $840k. 21 officers and directors are on file.
Code P open-market purchases from SEC Form 4 filings, non-derivative, excluding scheduled 10b5-1 plans. Nothing here is investment advice.
AVNT's recent reports: the day-one move, then what the following quarter actually did.
| report | day one | next quarter |
|---|---|---|
| 2023-07-28 | -4.1% | -12.0% |
| 2023-11-03 | +8.0% | +12.3% |
| 2024-02-21 | +9.4% | +11.1% |
| 2024-05-08 | +1.5% | -7.1% |
Day-one is the close-to-close move around the filing. Nothing here is investment advice.
AVNT's latest 8-K filings: 2026-08-06 (items 2.02, 9.01); 2026-05-15 (items 5.07); 2026-05-07 (items 2.02, 9.01); 2026-04-27 (items 5.02); 2026-02-12 (items 2.02, 9.01).
Item codes are the SEC's own classification of what each report discloses. Dates link to the filing on EDGAR. Nothing here is investment advice.
Model solve date: 2026-Q2
Narrative composed: July 25, 2026
Each week boothcheck ranks the stocks whose prices are betting on the most. Read the most stretched bets archive →
boothcheck is also on Android. Get the app on Google Play →
For informational and research purposes only. Not investment advice. Not a recommendation to buy, sell, or hold any security. boothcheck is not a registered investment adviser. Past performance does not guarantee future results.